Nevertheless, he said, there has not been enough progress scaling up the production of mRNA vaccines, which are made by Moderna — the Cambridge-based company that received billions of dollars in government subsidies to develop its highly effective vaccine and has profited handsomely — and a partnership between Pfizer, which is an American company, and BioNTech, which is German.
Read the full article at The Boston Globe here.